TRIM28 and neoplasm: We dissected out all xenograft tumors at the endpoint (Fig. 7e) and found significantly (T-test, P = 0.001) reduced endpoint tumor weight without affecting overall mice body weight in the TRIM28-knockdown group (Fig. 7f & Supplementary Fig. 7d).